FDA product code MJL: Eia, Blastomyces Dermatitidis

MJL is the FDA product code for eia, blastomyces dermatitidis. It is a Class II device, regulated under 21 CFR 866.3060 and reviewed by the Microbiology panel. FDA has cleared 2 510(k) submissions under MJL, from 2 different applicants. The average 510(k) review took 54 days (median 54).

Classification

FieldValue
Device nameEia, Blastomyces Dermatitidis
Device classClass II
Regulation21 CFR 866.3060
Review panelMI — Microbiology
Medical specialtyMicrobiology
Premarket route510(k) exempt

Top MJL applicants

ApplicantClearancesLatest
Meridian Diagnostics, Inc.11992-10-05
Aries Medical, Inc.11984-03-02

Most recent MJL clearances

510(k)ApplicantDeviceDecision dateReview days
K923859Meridian Diagnostics, Inc.PREMIER BLASTOMYCES1992-10-0566
K840201Aries Medical, Inc.EPIDURAL CATHETER TRAY1984-03-0243

Recalls for MJL devices

openFDA lists no recalls for product code MJL.

Frequently asked questions

What is FDA product code MJL?

MJL is the FDA product code for eia, blastomyces dermatitidis. It is a Class II device, regulated under 21 CFR 866.3060 and reviewed by the Microbiology panel.

What device class is MJL?

Class II, regulation 21 CFR 866.3060. Typical premarket route: 510(k) exempt.

How long does a 510(k) take for product code MJL?

Across 2 cleared submissions the average was 54 days from receipt to decision (median 54).

Which companies have the most MJL clearances?

Meridian Diagnostics, Inc. (1); Aries Medical, Inc. (1).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Microbiology product codes · FDA product code lookup